Individuals Stopping Anti-Obesity Medications Gain Back Pounds Four Times Faster Compared to Those on Conventional Diets
New research suggests that people who stop using popular weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who end conventional diet and exercise plans.
Published data in a leading medical journal demonstrates that while obese people often shed a large proportion of their body weight while on the medication, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"Individuals purchasing such treatments need to be aware of the risk of fast weight regain when the medication is stopped," stated expert Dr. Susan Jebb.
Such speed of recovery suggests a reversion to starting weight in about 18 months.
Analyzing Treatments
The study, which reviewed 37 of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with conventional dieting.
Researchers note that individuals who shed pounds through lifestyle changes alone generally experience a less rapid creep back—perhaps 100 grams monthly—once they finish.
Understanding the Quick Regain
Doctors believe the mechanism of the drugs accounts for the accelerated weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement results in appetite is unsuppressed, making overeating much more probable."
A Chronic Issue?
The NHS advise the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts argue that, considering the high risk of relapse, the therapy is often life-long.
This perspective is reinforced by pharmaceutical companies, who note that the results "emphasize the persistent character of excess weight," akin to managing conditions like high blood pressure.
User Testimonies
Users who have discontinued the jabs describe a powerful return of cravings.
"It was like a trigger that goes on and you become starving," said an individual.
This challenge is worsened if patients have not adopted sustainable dietary or behavioural modifications during treatment.
Significant Use
Figures suggest that a significant number of people in the UK have tried these injections in the past year, with interest remaining high.
- Use is greater among women than men.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic cure and long-term success relies on integrated lifestyle support.